🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Diabetes Registry Graz for Biomarker Research

Recruitingn/aAges 18 Years - 99 YearsAllMedical University of Graz
NCT05324488 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The Diabetes registry for biomarker research Graz is a prospective cohort-study including subjects with type 1 and type 2 diabetes, rare types of diabetes, obesity and dyslipidemia, aiming to collect data, blood and urine samples of all subjects on an annual basis.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * 18 - 99 years * Informed consent has to be given in written form * At least one of the following diseases: * Type 1 diabetes * Type 2 diabetes * Type 3 diabetes * Maturity onset diabetes of young (MODY) * Late onset diabetes of the adult (LADA) * Adipositas (BMI \> 30kg/m2) * Lipid metabolism disorder Exclusion Criteria: * No written informed consent * No willingness to participate in this registry
💊

What it tests

  • No intervention
📍

Where

1 site
Medical University of Graz
Graz, Austria
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy